Anabel Bennett López

Experienced communications professional with a focus on science and innovation

Webinars

At Inpart, I was the lead webinar host for the online Global Challenge event programme. I was responsible for webinar logistics, content design, internal and external stakeholder engagement, content marketing, and reporting. See the webinar recordings linked below.

Inpart •

Sustainable agriculture and food: R&D trends and predictions 2024

The conversation will center around our R&D trends report, analyzing partnering trends through our online platform, and generating exclusive insights into the future of food and agriculture science.

What types of early-stage research are industry most interested in? What are the key obstacles to commercializing new products and solutions aimed at sustainably feeding global populations? And what will the next five-years look like for scientific innovation?
Inpart •

Partner with R&D teams working on agritech and food - CP Foods · Insights

In the fourth event of our latest online partnering event series, we spoke with the Director of Open Innovation at Charoen Pokphand Foods (CP Foods) about their R&D priorities, their collaboration and funding opportunities, and the research they’re looking for from academia, biotech companies, and startups.Speaker:Format: One 15 minute presentation followed by live Q&A (~40 minutes)TimestampsAs part of our current cutting-edge science and assets to sustainably feed global populations, CP Foods h...
Inpart •

Top sustainable materials R&D trends for 2024

In the final event of our Global Challenge campaign on sustainable materials, we host leading experts from industry and academia to provide a unique view on the future of research and innovation working towards a circular economy. Format: Presentation, panel discussion, and live Q&A (55 mins)Timestamps:In this panel event, we will discuss key findings from our Global Challenge R&D trends report which identifies early-stage research and assets from institutes and startups worldwide that industry...
Inpart •

Partner with Bel and Carrot Ventures agritech and food R&D · Insights

In the third event of our latest online partnering event series, we spoke with R&D and innovation leads at Carrot Ventures and Groupe Bel about their R&D priorities, their collaboration and funding opportunities, and the research they’re looking for from academia, biotech companies, and startups.Speakers:Format: Two 15 minute presentations followed by live Q&A (~50 minutes)TimestampsAs part of our current cutting-edge science and assets to sustainably feed global populations, Le Groupe Bel and C...

Partner with Hochland & Incotec agritech and food R&D · Insights

In the second event of our latest online partnering event series, we spoke with R&D and innovation leads at Hochland and Incotec about their R&D priorities, their collaboration and funding opportunities, and the research they’re looking for from academia, biotech companies, and startups.Speakers:Format: Two 15 minute presentations followed by live Q&A (~50 minutes)TimestampsAs part of our current Global Challenge campaign seeking cutting-edge science and assets to sustainably feed global populat...
Inpart •

Partner with Merck & GFI agritech and food R&D · Insights

In the first event of our latest online partnering event series, we spoke with R&D and innovation leads at The Good Food Institute Europe and Merck about their alternative protein R&D priorities, their collaboration and funding opportunities, and the research they’re looking for from academia, biotech companies, and startups.Speakers:Format: Two 15 minute presentations followed by live Q&A (~50 minutes)Timestamps01:42 - Introduction to Inpart 04:45 - Seren Kell, The Good Food Institue Europe, In...
IN-PART •

Webinar | Partner with world-leading academics on sustainable materials R&D

In the third event of our latest online events series, as part of our current Global Challenge uncovering the next generation of sustainable materials research and innovation, with leading academics at Imperial College London and NC State University about their latest sustainable materials research and partnering opportunities for teams in industry R&D. Speakers:Dr Agnieszka Brandt-Talbot, Imperial College LondonAgnieszka is a Lecturer in the Department of Chemistry at Imperial College London an...
IN-PART •

Partner with Avery Dennison and Ecover to solve their R&D challenges | IN-PART

In the second event of our latest online events series, we spoke with R&D and external innovation leads at Avery Dennison and Ecover about their sustainable materials R&D priorities, and the research they’re looking for from academia and outlicensing SMEs.Speakers:Avery Dennison Corporation is a global materials science and digital identification solutions company. It provides branding and information labelling solutions, including pressure-sensitive materials, radio-frequency identification (RF...
IN-PART •

Partner with Eastman and WestRock to solve their R&D challenges | IN-PART

In the first event of our latest online events series, we spoke with R&D and external innovation leads at Eastman and WestRock about their sustainable materials R&D priorities, and the research they’re looking for from academia and outlicensing SMEs.Speakers:Founded in 1920, Eastman is a global speciality materials company that produces a broad range of products found in items people use every day. Their 14,000 employees in more than 100 countries listen to the needs of society and partners to d...
IN-PART •

Partner with world-leading rare disease academics | IN-PART Virtual Series

In the sixth and final event of our latest Virtual Series, we spoke with three leading rare disease academics from UCLA, University of Birmingham, and LMU Munich.This live virtual event was an opportunity to partner with world-leading academics and find out about their new and unsurfaced rare disease research, and approach to partnering with teams in industry R&D. What to expect from this event recording:Format: 10-minute presentations from each academic followed by live Q&A (~60 minutes)This ev...
IN-PART •

Virtual partnering event with Global Genes/RARE-X | IN-PART

In the fifth event of our latest Virtual Series, we spoke with Karmen Trzupek, Senior Director of Scientific Programs at Global Genes.In this partnering event with Global Genes/RARE-X, we heard about the organisations’ rare disease innovation and collaboration priorities and how academia, industry R&D, and biotechs can partner with them and leverage the RARE-X platform.Format: Presentation followed by live Q&A (~40 minutes)TimestampsAs part of our current Global Challenge seeking novel rare dise...
IN-PART •

Partner with Sanofi to solve their R&D challenges | IN-PART

In the fourth event of our latest Virtual Series, we spoke with Olaf Ritzeler, Business Development and Licensing Director, Rare Diseases External Innovation at Sanofi.In this partnering event with Sanofi, we heard about their rare disease R&D priorities and the research they’re seeking from academia.Format: Presentation followed by live Q&A (~40 minutes)TimestampsAs part of our current Global Challenge seeking novel rare disease research and assets, Sanofi have shared their interests through th...
IN-PART •

Partner with General Inception to solve their R&D challenges | IN-PART

In the third event of our latest Virtual Series, we spoke with Kevin Hollevoet, Executive and Program Director, and Sara Jones PhD, Senior Director, Cell Engineering and Synthetic Biology at General Inception.In this partnering event with General Inception, we heard about their rare disease R&D priorities and the research they’re seeking from academia.Format: Presentation followed by live Q&A (~40 minutes) Timestamps As part of our current Global Challenge seeking novel rare disease research and...
IN-PART •

Partner with Ultragenyx to solve their R&D challenges | IN-PART

In the second event of our latest Virtual Series, we spoke with Chris Hamblett, Vice President, Business Development, and Mika Aoyagi-Scharber, Executive Director, Translational Research, Program & Portfolio Management at Ultragenyx. In this partnering event with Ultragenyx, we heard about their rare disease R&D priorities and the research they’re seeking from academia.Format: Presentation followed by live Q&A (~40 minutes)  As part of our current Global Challenge seeking novel rare disease rese...
IN-PART •

Partner with Mitsubishi Tanabe Pharma to solve their R&D challenges | IN-PART

In the first event of our latest Virtual Series, we spoke with Shin-ichiro Yasuda, Deputy Director of Mitsubishi Tanabe Pharma Co. Japan. After many years as a project leader of drug discovery programs for metabolic diseases, Shin moved to the open innovation team of Mitsubishi Tanabe Pharma in 2017. He obtained his PhD from University of Tsukuba, Japan and his MBA from the University of Warwick, UK. In this partnering event with Mitsubishi Tanabe Pharma, we heard about their rare disease R&D pr...
IN-PART •

Partnering event with The Institute of Cancer Research | IN-PART

In this partnering event with The Institute of Cancer Research, the first part of our partnering events with academia Virtual Series event, we spoke with leading academics about their research and innovations. They each presented their latest technology portfolios of next-generation immuno-oncology research, as well as current opportunities for collaboration with industry partners. View the one-page summary of their presentation via this shareable PDF.There is still time to request an introducti...
IN-PART •

Partner with Immunitas Therapeutics to solve their R&D challenges | IN-PART

In the third event of our latest Virtual Series, we spoke with Thomas Tan, Chief Scientific Officer at Immunitas Therapeutics. Dr Tan brings over 20 years of therapeutic research experience in both large and small biopharmaceutical settings across different disease areas, including infectious disease, autoimmunity, and oncology. In this partnering event with Immunitas Therapeutics, we heard about their R&D priorities and the research they’re looking for from academia. Format: Presentation follow...
IN-PART •

Partner with Tocris Bioscience to solve their R&D challenges | IN-PART

In thesecond event of our latest Virtual Series, we spoke with Marco Pinheiro, a Product Specialist at Tocris Bioscience. Marco Pinheiro is a product specialist focused on Oncology at Tocris, a Bio-techne brand and renowned supplier of chemical tools to the research community. Coming from an academic background, Marco is keen on identifying valuable research tools to drive innovation and therapeutic discovery within cancer research. In this partnering event with Tocris Bioscience, we heard about...
IN-PART •

Partner with MSD to solve their R&D challenges | IN-PART

In the first event of our latest Virtual Series, we spoke with Daniel Marshall, Director of Oncology Business Development at MSD. Daniel is currently the Director of Business Development for MSD, leading on oncology BD&L for Europe and the Middle East. He holds a PhD in Immunology from the National Institute for Medical Research and previously spent several years in Biotech venture capital investment. In this partnering event with MSD, we heard about their R&D priorities and the research they’re...
IN-PART •

Successfully leverage the microbiome | IN-PART Virtual Series

In Event 3 of our Virtual Series, we spoke with a mixed-sector panel to discuss the top priorities and challenges within microbiome research that need to be addressed, as well as what their institutes and organisations are doing to create microbiome solutions.   Format: Panel discussion followed by live Q&A (~60 minutes)Moderator | Jim Cornell, Editor in Chief, LabiotechJim is Editor in Chief at IN-PART’s partner company Labiotech, the leading online media for the biotech industry in Europe. Jim...
IN-PART •

Partner with world-leading academics at the NIH | IN-PART

In the second event of our Virtual Series, we hosted an ‘academic partnering opportunity’ event with the National Institutes of Health and National Cancer Institute to find out more about their microbiome research programmes, expertise, and collaboration opportunities.If you would like to speak with our guests from the NIH/NCI please fill in the introduction request form, or contact Joe at IN-PART (joseph.ferner@in-part.co.uk) who will connect you.  Format: Presentation followed by live Q&A (~45...
IN-PART •

Partner with Colgate-Palmolive to solve their R&D challenges | IN-PART

In the third event of our latest Virtual Series, we spoke with Dr. Venda Maloney, Director, Oral Care Early Research at Colgate-Palmolive – who are working to ensure a healthier future for people, their pets, and our planet. We heard about their R&D priorities and the research they’re looking for from academia.Format: Presentation followed by live Q&A (~30 minutes)As part of our current Global Challenge campaign on the human microbiome, VIC Technology Ventures have shared their interests through...
IN-PART •

Industry partnering opportunity | VIC Technology Venture Development

In the second event of our latest Virtual Series, we spoke with Danielle France, Fellow and Michael Artinger, VP and Managing Director, at VIC Technology Venture Development – who source top medtech and biotech innovation from research institutions around the world and form new companies to commercialise the chosen technologies. We heard about their R&D priorities and the research they’re looking for from academia. Format: Presentation followed by live Q&A (~40 minutes)As part of our current Glo...
IN-PART •

Partner with Caelus Health to solve their R&D challenges | IN-PART

In the first event of our latest Virtual Series, we spoke with Luc Sterkman, CEO at Caelus Health– who has an extensive track record in the life sciences industry, including senior management positions in biotech, food and pharma industries. We heard about their R&D priorities and the research they’re looking for from academia.Format: Presentation followed by live Q&A (~40 minutes)As part of our current Global Challenge campaign on the human microbiome, Caelus Health have shared their interests...
Load More